• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药/膳食补充剂与药物相互作用的日常评估:一项试点研究。

Everyday Evaluation of Herb/Dietary Supplement-Drug Interaction: A Pilot Study.

作者信息

Souza-Peres Joao Victor, Flores Kimberly, Umloff Bethany, Heinan Michelle, Herscu Paul, Babos Mary Beth

机构信息

DeBusk College of Osteopathic Medicine, Lincoln Memorial University, Harrogate, TN 37752, USA.

School of Medical Sciences, Lincoln Memorial University, Harrogate, TN 37752, USA.

出版信息

Medicines (Basel). 2023 Feb 28;10(3):20. doi: 10.3390/medicines10030020.

DOI:10.3390/medicines10030020
PMID:36976309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10055849/
Abstract

A lack of reliable information hinders the clinician evaluation of suspected herb-drug interactions. This pilot study was a survey-based study conceived as a descriptive analysis of real-life experiences with herb-drug interaction from the perspective of herbalists, licensed health-care providers, and lay persons. Reported dietary supplement-drug interactions were evaluated against the resources most commonly cited for the evaluation of potential supplement-drug interactions. Disproportionality analyses were performed using tools available to most clinicians using data from the U.S. Federal Adverse Event Reporting System (FAERS) and the US Center for Food Safety and Applied Nutrition (CFSAN) Adverse Event Reporting System (CAERS). Secondary aims of the study included exploration of the reasons for respondent use of dietary supplements and qualitative analysis of respondent's perceptions of dietary supplement-drug interaction. While agreement among reported supplement-drug interactions with commonly cited resources for supplement-drug interaction evaluation and via disproportionality analyses through FAERS was low, agreement using data from CAERS was high.

摘要

缺乏可靠信息阻碍了临床医生对疑似草药-药物相互作用的评估。这项初步研究是一项基于调查的研究,旨在从草药师、持牌医疗保健提供者和普通民众的角度,对草药-药物相互作用的实际生活经验进行描述性分析。针对评估潜在补充剂-药物相互作用时最常引用的资源,对报告的膳食补充剂-药物相互作用进行了评估。使用大多数临床医生都能使用的工具,利用来自美国联邦不良事件报告系统(FAERS)和美国食品安全与应用营养中心(CFSAN)不良事件报告系统(CAERS)的数据进行了不成比例分析。该研究的次要目标包括探究受访者使用膳食补充剂的原因,以及对受访者对膳食补充剂-药物相互作用的认知进行定性分析。虽然报告的补充剂-药物相互作用与补充剂-药物相互作用评估的常用引用资源之间的一致性较低,且通过FAERS进行的不成比例分析得出的一致性也较低,但使用CAERS数据得出的一致性较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/4adacdeecca7/medicines-10-00020-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/b2cf73edb11f/medicines-10-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/9fd9c260ac12/medicines-10-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/c959332d85a1/medicines-10-00020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/3f37e925dd94/medicines-10-00020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/4adacdeecca7/medicines-10-00020-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/b2cf73edb11f/medicines-10-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/9fd9c260ac12/medicines-10-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/c959332d85a1/medicines-10-00020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/3f37e925dd94/medicines-10-00020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059b/10055849/4adacdeecca7/medicines-10-00020-g005.jpg

相似文献

1
Everyday Evaluation of Herb/Dietary Supplement-Drug Interaction: A Pilot Study.草药/膳食补充剂与药物相互作用的日常评估:一项试点研究。
Medicines (Basel). 2023 Feb 28;10(3):20. doi: 10.3390/medicines10030020.
2
Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.2004-2013 年,美国食品和药物管理局食品安全与应用营养中心不良事件报告系统中的膳食补充剂不良事件报告数据。
Ann Pharmacother. 2018 May;52(5):431-438. doi: 10.1177/1060028017744316. Epub 2017 Nov 24.
3
Detecting Signals of Dietary Supplement Adverse Events from the CFSAN Adverse Event Reporting System (CAERS).从美国食品药品监督管理局食品安全与应用营养中心不良事件报告系统(CAERS)中检测膳食补充剂不良事件信号。
AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:258-266. eCollection 2019.
4
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.含红曲米的膳食补充剂的不良事件:FAERS 和 CAERS 报告系统的比较分析。
Drug Saf. 2018 Aug;41(8):745-752. doi: 10.1007/s40264-018-0661-3.
5
Dietary supplement adverse events: report of a one-year poison center surveillance project.膳食补充剂不良事件:一项为期一年的中毒控制中心监测项目报告。
J Med Toxicol. 2008 Jun;4(2):84-92. doi: 10.1007/BF03160960.
6
Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).美国食品和药物管理局不良事件报告系统(FAERS)中同时使用 CYP3A4 相互作用和 CYP3A4 非相互作用抗癌药物的伴随植物性膳食补充剂的不良事件报告模式。
Expert Opin Drug Saf. 2019 Feb;18(2):145-152. doi: 10.1080/14740338.2019.1562546. Epub 2018 Dec 27.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.美国-墨西哥边境地区老年人多重用药、多种草药使用、营养补充剂使用情况及潜在产品相互作用的患病率:一项基于问卷调查的描述性研究。
Drugs Aging. 2009;26(5):423-36. doi: 10.2165/00002512-200926050-00006.
9
Application of FDA adverse event report data to the surveillance of dietary botanical supplements.美国食品药品监督管理局不良事件报告数据在膳食植物补充剂监测中的应用
Ann Pharmacother. 2008 May;42(5):653-60. doi: 10.1345/aph.1K611. Epub 2008 Apr 8.
10
Serious Adverse Events Reported with Dietary Supplement Use in the United States: A 2.5 Year Experience.美国膳食补充剂使用报告的严重不良事件:2.5年的经验。
J Diet Suppl. 2020;17(2):227-248. doi: 10.1080/19390211.2018.1513109. Epub 2018 Dec 4.

引用本文的文献

1
Predictive Modeling of Pharmacokinetic Drug-Drug and Herb-Drug Interactions in Oncology: Insights From PBPK Studies.肿瘤学中药代动力学药物-药物及草药-药物相互作用的预测模型:基于生理药代动力学研究的见解
Int J Toxicol. 2025 Jun 11;44(5):10915818251345116. doi: 10.1177/10915818251345116.
2
Dietary Supplements for Weight Loss and Drug Interactions.用于减肥的膳食补充剂与药物相互作用
Pharmaceuticals (Basel). 2024 Dec 9;17(12):1658. doi: 10.3390/ph17121658.
3
Perspectives, Experiences, and Practices of Healthcare Professionals and Patients Towards Herb-Drug Interaction: A Systematic Review of Qualitative Studies.

本文引用的文献

1
Hepatotoxicity due to herbal dietary supplements: Past, present and the future.草药膳食补充剂导致的肝毒性:过去、现在和未来。
Food Chem Toxicol. 2022 Nov;169:113445. doi: 10.1016/j.fct.2022.113445. Epub 2022 Sep 29.
2
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions.利用临床实践数据进行真实世界证据研究的可重复性,以支持监管和覆盖决策。
Nat Commun. 2022 Aug 31;13(1):5126. doi: 10.1038/s41467-022-32310-3.
3
Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database.
医疗保健专业人员和患者对草药-药物相互作用的观点、经验和实践:定性研究的系统评价
Phytother Res. 2025 Jan;39(1):505-520. doi: 10.1002/ptr.8384. Epub 2024 Nov 13.
4
Survey of Potential Drug Interactions, Use of Non-Medical Health Products, and Immunization Status among Patients Receiving Targeted Therapies.接受靶向治疗患者的潜在药物相互作用、非医疗健康产品使用及免疫状态调查。
Pharmaceuticals (Basel). 2024 Jul 14;17(7):942. doi: 10.3390/ph17070942.
5
Food-drug interactions risk management: An emergent piece of pharmacovigilance systems.食品-药物相互作用风险管理:药物警戒系统的一个新领域。
Pharmacol Res Perspect. 2024 Aug;12(4):e1245. doi: 10.1002/prp2.1245.
6
Safe use elements of finished herbal products: insights from consumers and practitioners in Malaysia.安全使用草药制品成品的要素:来自马来西亚消费者和从业者的见解。
BMC Complement Med Ther. 2024 Jul 3;24(1):252. doi: 10.1186/s12906-024-04546-7.
7
Herbal Interactions with Cardiac Medications: A Comprehensive Review of Potential Interactions between Herbal Drugs and Commonly Prescribed Cardiac Medications.草药与心脏药物的相互作用:草药与常用心脏药物之间潜在相互作用的全面综述。
Curr Drug Saf. 2025;20(2):94-119. doi: 10.2174/0115748863289321240424063819.
基于世界卫生组织全球数据库 VigiBase 的真实生活中的草药抗癌药物相互作用。
Sci Rep. 2022 Aug 19;12(1):14178. doi: 10.1038/s41598-022-17704-z.
4
Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies.真实世界中肿瘤患者中草药-药物相互作用的研究:基于药物流行病学研究的范围综述。
Phytomedicine. 2022 Aug;103:154247. doi: 10.1016/j.phymed.2022.154247. Epub 2022 Jun 7.
5
Adverse Effects Associated with Multiple Categories of Dietary Supplements: The Military Dietary Supplement Use Study.与多种类别的膳食补充剂相关的不良影响:军事膳食补充剂使用研究。
J Acad Nutr Diet. 2022 Oct;122(10):1851-1863. doi: 10.1016/j.jand.2022.01.014. Epub 2022 Feb 2.
6
A systematic review on botany, processing, application, phytochemistry and pharmacological action of Radix Rehmnniae.关于地黄的植物学、加工、应用、植物化学和药理学作用的系统评价。
J Ethnopharmacol. 2022 Mar 1;285:114820. doi: 10.1016/j.jep.2021.114820. Epub 2021 Nov 10.
7
Overview of Current Herb-Drug Interaction Databases.当前草药-药物相互作用数据库概述。
Drug Metab Dispos. 2022 Jan;50(1):86-94. doi: 10.1124/dmd.121.000420. Epub 2021 Oct 25.
8
Herb-Drug Interactions: Worlds Intersect with the Patient at the Center.草药-药物相互作用:以患者为中心,不同领域相互交织。
Medicines (Basel). 2021 Aug 5;8(8):44. doi: 10.3390/medicines8080044.
9
Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.门诊口服抗肿瘤药物患者的实际药物-药物和草药-药物相互作用:与数据库的比较。
J Cancer Res Clin Oncol. 2022 Mar;148(3):707-718. doi: 10.1007/s00432-021-03645-z. Epub 2021 Apr 29.
10
Food constituent- and herb-drug interactions in oncology: Influence of quantitative modelling on Drug labelling.肿瘤学中的食物成分和草药-药物相互作用:定量建模对药物标签的影响。
Br J Clin Pharmacol. 2021 Oct;87(10):3988-4000. doi: 10.1111/bcp.14822. Epub 2021 Apr 14.